Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bacterial Infections and Mycoses

Free Subscription Articles published in J Antimicrob Chemother Retrieve available abstracts of 149 articles: HTML format Text format

Single Articles

January 2012
1. MARURI F , Sterling TR, Kaiga AW, Blackman A, et al
   A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. TANG HJ , Chen CC, Cheng KC, Toh HS, et al
   In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. OSLAND AM , Vestby LK, Fanuelsen H, Slettemeas JS, et al
   Clonal diversity and biofilm-forming ability of methicillin-resistant Staphylococcus pseudintermedius.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. REDDY VM , Dubuisson T, Einck L, Wallis RS, et al
   SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. KIRKPATRICK WR , Najvar LK, Vallor AC, Wiederhold NP, et al
   Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. LAFAURIE M , Porcher R, Donay JL, Touratier S, et al
   Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. DEMIR T , Coplu N, Bayrak H, Turan M, et al
   Panton-Valentine leucocidin gene carriage among Staphylococcus aureus strains recovered from skin and soft tissue infections in Turkey.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. SENDI P , Zimmerli W
   Comment on: Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
9. VALDEZATE S , Miranda C, Navarro A, Freitas AR, et al
   Clonal outbreak of ST17 multidrug-resistant Enterococcus faecium harbouring an Inc18-like::Tn1546 plasmid in a haemo-oncology ward of a Spanish hospital.
   J Antimicrob Chemother. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. JOHNSON AP , Davies J, Guy R, Abernethy J, et al
    Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years.
    J Antimicrob Chemother. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
11. KUCH A , Willems RJ, Werner G, Coque TM, et al
    Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. NAGANO N , Nagano Y, Toyama M, Kimura K, et al
    Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. DE ALMEIDA LM , Lincopan N, de Araujo MR, Mamizuka EM, et al
    Dissemination of the linezolid-resistant Staphylococcus epidermidis clone ST2 exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary-care hospital, Brazil.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
14. GRIM SA , Berger K, Teng C, Gupta S, et al
    Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. STUCKI A , Cottagnoud M, Acosta F, Egerman U, et al
    Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CHANG HJ , Hsu PC, Yang CC, Siu LK, et al
    Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. MOREILLON P , Bizzini A, Giddey M, Vouillamoz J, et al
    Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KHAN MS , Ahmad I
    Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. HAENNI M , Saras E, Chatre P, Medaille C, et al
    A USA300 variant and other human-related methicillin-resistant Staphylococcus aureus strains infecting cats and dogs in France.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. ABBATE E , Vescovo M, Natiello M, Cufre M, et al
    Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
21. MITCHELL G , Lafrance M, Boulanger S, Seguin DL, et al
    Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. JOSON J , Heidari A
    Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure--authors' response.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
23. HUANG TS , Kunin CM, Yan BS, Chen YS, et al
    Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. LOZANO C , Rezusta A, Gomez P, Gomez-Sanz E, et al
    High prevalence of spa types associated with the clonal lineage CC398 among tetracycline-resistant methicillin-resistant Staphylococcus aureus strains in a Spanish hospital.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. HOLMBERG A , Morgelin M, Rasmussen M
    Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. LIU H , Wang Y, Wu C, Schwarz S, et al
    A novel phenicol exporter gene, fexB, found in enterococci of animal origin.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. TOULET D , Debarre C, Imbert C
    Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. CAMOU F
    Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
29. SIMONETTI O , Cirioni O, Lucarini G, Orlando F, et al
    Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. KELESIDIS T
    Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
31. CHOPRA S , Matsuyama K, Tran T, Malerich JP, et al
    Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
32. SALERI N , Dembele SM, Villani P, Carvalho AC, et al
    Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. CHOWDHARY A , Kathuria S, Randhawa HS, Gaur SN, et al
    Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. HAUSCHILD T , Fessler AT, Kadlec K, Billerbeck C, et al
    Detection of the novel vga(E) gene in methicillin-resistant Staphylococcus aureus CC398 isolates from cattle and poultry.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
35. NWEZE EI , Ghannoum A, Chandra J, Ghannoum MA, et al
    Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. FOURNIER P , Schwebel C, Maubon D, Vesin A, et al
    Antifungal use influences Candida species distribution and susceptibility in the intensive care unit.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. PICHEREAU S , Moran JJ, Hayney MS, Shukla SK, et al
    Concentration-dependent effects of antimicrobials on Staphylococcus aureus toxin-mediated cytokine production from peripheral blood mononuclear cells.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
38. LUCKE K , Hombach M, Friedel U, Ritter C, et al
    Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiST.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. JOSON J , Grover C, Downer C, Pujar T, et al
    Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure--authors' response.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
40. RODRIGUEZ-AVIAL I , Culebras E, Betriu C, Morales G, et al
    In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. IDELEVICH EA , Kriegeskorte A, Stubbings W, Kahl BC, et al
    Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. VAN DUIJKEREN E , Catry B, Greko C, Moreno MA, et al
    Review on methicillin-resistant Staphylococcus pseudintermedius.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. GAGNON S , Levesque S, Lefebvre B, Bourgault AM, et al
    vanA-containing Enterococcus faecium susceptible to vancomycin and teicoplanin because of major nucleotide deletions in Tn1546.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. CLEVELAND KO , Memon KA
    Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
45. JENKINS R , Burton N, Cooper R
    Manuka honey inhibits cell division in methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
46. KIMURA K , Nagano N, Nagano Y, Wachino JI, et al
    Predominance of sequence type 1 group with serotype VI among group B streptococci with reduced penicillin susceptibility identified in Japan.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. PFALLER MA , Watanabe N, Castanheira M, Messer SA, et al
    Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. VANDENDRIESSCHE S , Kadlec K, Schwarz S, Denis O, et al
    Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. KING ST , Usery JB, Holloway K, Koeth L, et al
    Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
50. TWILLA JD , Gelfand MS, Cleveland KO, Usery JB, et al
    Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
51. TACCONELLI E , Johnson AP
    National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the Netherlands.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
52. LAI CC , Tan CK, Huang YT, Liao CH, et al
    Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
53. MIRANDA-ZAPICO I , Eraso E, Hernandez-Almaraz JL, Lopez-Soria LM, et al
    Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. CHEN L , Li N, Liu M, Zhang J, et al
    High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
55. WANG Y , Wang Y, Wu CM, Schwarz S, et al
    Detection of the staphylococcal multiresistance gene cfr in Proteus vulgaris of food animal origin.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. DUPONT H , Friggeri A, Touzeau J, Airapetian N, et al
    Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. REY-JURADO E , Tudo G, Borrell S, Alcaide F, et al
    Impaired fitness of Mycobacterium tuberculosis resistant isolates in a cell culture model of murine macrophages.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. SHI D , Li L, Zhao Y, Jia Q, et al
    Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. WALRAVEN CJ , North MS, Marr-Lyon L, Deming P, et al
    Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. VAN HAL SJ , Barbagiannakos T, Jones M, Wehrhahn MC, et al
    Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. MOSTOFSKY E , Lipsitch M, Regev-Yochay G
    Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. CREMADES R , Rodriguez JC, Garcia-Pachon E, Galiana A, et al
    Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
63. AMMERLAAN HS , Kluytmans JA, Berkhout H, Buiting A, et al
    Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. AMMERLAAN HS , Kluytmans JA, Berkhout H, Buiting A, et al
    Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. KING EA , McCoy D, Desai S, Nyirenda T, et al
    Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. ALT S , Mitchenall LA, Maxwell A, Heide L, et al
    Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. PIERPAOLI E , Cirioni O, Barucca A, Orlando F, et al
    Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
68. JOSON J , Grover C, Downer C, Pujar T, et al
    Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
69. YOON YK , Lee SE, Lee J, Kim HJ, et al
    Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. XU HB , Jiang RH, Li L
    Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. STURDY A , Goodman A, Jose RJ, Loyse A, et al
    Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. VAN DEN BOOGAARD J , Semvua HH, van Ingen J, Mwaigwisya S, et al
    Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. GUZMAN JD , Wube A, Evangelopoulos D, Gupta A, et al
    Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
74. FISCHER A , Yang SJ, Bayer AS, Vaezzadeh AR, et al
    Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. HAENNI M , Chatre P, Boisset S, Carricajo A, et al
    Staphylococcal nasal carriage in calves: multiresistant Staphylococcus sciuri and immune evasion cluster (IEC) genes in methicillin-resistant Staphylococcus aureus ST398.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
76. AHMAD Z , Fraig MM, Pinn ML, Tyagi S, et al
    Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. ALMEIDA DA SILVA PE , Palomino JC
    Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. JOHNSON AP
    Methicillin-resistant Staphylococcus aureus: the European landscape.
    J Antimicrob Chemother. 2011;66 Suppl 4:iv43-iv48.
    PubMed     Text format     Related articles   
    
    
    
    
79. GOULD IM
    Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2011;66 Suppl 4:iv17-iv21.
    PubMed     Text format     Related articles   
    
    
    
    
80. KOERNER R , Hope R
    Preface. The evidence for the clinical role of linezolid beyond its licence.
    J Antimicrob Chemother. 2011;66 Suppl 4:iv1.
    PubMed     Text format     Related articles   
    
    
    
    
81. DRYDEN MS
    Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.
    J Antimicrob Chemother. 2011;66 Suppl 4:iv7-iv15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. GOULD FK
    Linezolid: safety and efficacy in special populations.
    J Antimicrob Chemother. 2011;66 Suppl 4:iv3-iv6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. GARAZZINO S , Tovo PA
    Clinical experience with linezolid in infants and children.
    J Antimicrob Chemother. 2011;66 Suppl 4:iv23-iv41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
84. KHATIB R , Jose J, Musta A, Sharma M, et al
    Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
85. PRATES RA , Kato IT, Ribeiro MS, Tegos GP, et al
    Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
86. SATO T , Kawai Y, Matsuda H, Tateda K, et al
    In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
87. LEWIS RE , Liao G, Hou J, Prince RA, et al
    Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. ALANIO A , Cordonnier C, Bretagne S
    Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies--authors' response.
    J Antimicrob Chemother. 2011;66:955.
    PubMed     Text format     Related articles   
    
    
    
    
89. VERWEIJ PE , Camps SM, Kema GH, Melchers WJ, et al
    Comment on: Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
    J Antimicrob Chemother. 2011;66:954-5.
    PubMed     Text format     Related articles   
    
    
    
    
90. JACQUELINE C , Amador G, Batard E, Le Mabecque V, et al
    Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    J Antimicrob Chemother. 2011;66:863-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. MENA A , Vazquez P, Castro A, Lopez S, et al
    Clinical experience of raltegravir-containing regimens in HIV-infected patients during rifampicin-containing treatment of tuberculosis.
    J Antimicrob Chemother. 2011;66:951-2.
    PubMed     Text format     Related articles   
    
    
    
    
92. DRAGO L , Nicola L, Rodighiero V, Larosa M, et al
    Comparative evaluation of synergy of combinations of {beta}-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae.
    J Antimicrob Chemother. 2011;66:845-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. LAFLEUR MD , Lucumi E, Napper AD, Diamond SL, et al
    Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms.
    J Antimicrob Chemother. 2011;66:820-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. BOURDON N , Fines-Guyon M, Thiolet JM, Maugat S, et al
    Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08.
    J Antimicrob Chemother. 2011;66:713-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. MARTIN A , Paasch F, Docx S, Fissette K, et al
    Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2011;66:827-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. SIU GK , Zhang Y, Lau TC, Lau RW, et al
    Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2011;66:730-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. CIRIONI O , Kamysz E, Ghiselli R, Kamysz W, et al
    Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis.
    J Antimicrob Chemother. 2011;66:859-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. LISMOND A , Carbonnelle S, Tulkens PM, Van Bambeke F, et al
    Efflux of novel quinolones in contemporary Streptococcus pneumoniae isolates from community-acquired pneumonia.
    J Antimicrob Chemother. 2011;66:948-51.
    PubMed     Text format     Related articles   
    
    
    
    
99. KIBE S , Adams K, Barlow G
    Diagnostic and prognostic biomarkers of sepsis in critical care.
    J Antimicrob Chemother. 2011;66 Suppl 2:ii33-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. PROWLE JR , Heenen S, Singer M
     Infection in the critically ill--questions we should be asking.
     J Antimicrob Chemother. 2011;66 Suppl 2:ii3-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. MCKENZIE C
     Antibiotic dosing in critical illness.
     J Antimicrob Chemother. 2011;66 Suppl 2:ii25-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. DANIELS R
     Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective).
     J Antimicrob Chemother. 2011;66 Suppl 2:ii11-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. JOHNSON AP , Leibovici L
     Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil. Preface.
     J Antimicrob Chemother. 2011;66 Suppl 3:iii1.
     PubMed     Text format     Related articles   
     
     
     
     
104. LOW DE , File TM Jr, Eckburg PB, Talbot GH, et al
     FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
     J Antimicrob Chemother. 2011;66 Suppl 3:iii33-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. FILE TM JR , Low DE, Eckburg PB, Talbot GH, et al
     FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
     J Antimicrob Chemother. 2011;66 Suppl 3:iii19-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. JONES RN , Farrell DJ, Mendes RE, Sader HS, et al
     Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.
     J Antimicrob Chemother. 2011;66 Suppl 3:iii69-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. DRUSANO GL
     What are the properties that make an antibiotic acceptable for therapy of community-acquired pneumonia?
     J Antimicrob Chemother. 2011;66 Suppl 3:iii61-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. RANK DR , Friedland HD, Laudano JB
     Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia.
     J Antimicrob Chemother. 2011;66 Suppl 3:iii53-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. CRITCHLEY IA , Eckburg PB, Jandourek A, Biek D, et al
     Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
     J Antimicrob Chemother. 2011;66 Suppl 3:iii45-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. RAMIREZ JA , Anzueto AR
     Changing needs of community-acquired pneumonia.
     J Antimicrob Chemother. 2011;66 Suppl 3:iii3-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. LAUDANO JB
     Ceftaroline fosamil: a new broad-spectrum cephalosporin.
     J Antimicrob Chemother. 2011;66 Suppl 3:iii11-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2011
112. DJOUHRI-BOUKTAB L , Alhanout K, Andrieu V, Raoult D, et al
     Squalamine ointment for Staphylococcus aureus skin decolonization in a mouse model.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. FRANCO A , Hasman H, Iurescia M, Lorenzetti R, et al
     Molecular characterization of spa type t127, sequence type 1 methicillin-resistant Staphylococcus aureus from pigs.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. KADLEC K , van Duijkeren E, Wagenaar JA, Schwarz S, et al
     Molecular basis of rifampicin resistance in methicillin-resistant Staphylococcus pseudintermedius isolates from dogs.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. ZHANEL GG , Rossnagel E, Nichol K, Cox L, et al
     Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. au
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. ENGSTROM A , Perskvist N, Werngren J, Hoffner SE, et al
     Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. NOVY P , Urban J, Leuner O, Vadlejch J, et al
     In vitro synergistic effects of baicalin with oxytetracycline and tetracycline against Staphylococcus aureus.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. SUBRT N , Mesak LR, Davies J
     Modulation of virulence gene expression by cell wall active antibiotics in Staphylococcus aureus.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. BLASCHITZ M , Hasanacevic D, Hufnagl P, Hasenberger P, et al
     Real-time PCR for single-nucleotide polymorphism detection in the 16S rRNA gene as an indicator for extensive drug resistance in Mycobacterium tuberculosis.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. ROSADO H , Rahman KM, Feuerbaum EA, Hinds J, et al
     The minor groove-binding agent ELB-21 forms multiple interstrand and intrastrand covalent cross-links with duplex DNA and displays potent bactericidal activity against methicillin-resistant Staphylococcus aureus.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. CAMPANERUT PA , Ghiraldi LD, Spositto FL, Sato DN, et al
     Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. VILLAR M , Marimon JM, Garcia-Arenzana JM, de la Campa AG, et al
     Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. KELLEY PG , Gao W, Ward PB, Howden BP, et al
     Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
124. HAMSON C , Walton KE, Collins J, Wilson L, et al
     Report of an outbreak of CO2-dependent methicillin-resistant Staphylococcus aureus on a regional liver transplant unit.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
125. CANTON R , Ruiz-Garbajosa P, Chaves RL, Johnson AP, et al
     A potential role for daptomycin in enterococcal infections: what is the evidence?--authors' response.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
126. SONG JH , Hsueh PR, Chung DR, Ko KS, et al
     Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. SHIN J , Baek JY, Kim SH, Song JH, et al
     Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
128. SYRE H , Grewal H
     Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing-authors' response.
     J Antimicrob Chemother. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
129. DE PAUW BE , Viscoli C
     Managing invasive fungal infections: relying on clinical instincts or on a rational navigation system?
     J Antimicrob Chemother. 2011;66 Suppl 1:i55-58.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. PAGANO L , Akova M, Dimopoulos G, Herbrecht R, et al
     Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.
     J Antimicrob Chemother. 2011;66 Suppl 1:i5-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. AGRAWAL S , Hope W, Sinko J, Kibbler C, et al
     Optimizing management of invasive mould diseases.
     J Antimicrob Chemother. 2011;66 Suppl 1:i45-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. MAERTENS J , Groll AH, Cordonnier C, de la Camara R, et al
     Treatment and timing in invasive mould disease.
     J Antimicrob Chemother. 2011;66 Suppl 1:i37-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. FREEMANTLE N , Tharmanathan P, Herbrecht R
     Systematic review and mixed treatment comparison of randomized evidence for empirical, pre-emptive and directed treatment strategies for invasive mould disease.
     J Antimicrob Chemother. 2011;66 Suppl 1:i25-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. CUENCA-ESTRELLA M , Bassetti M, Lass-Florl C, Racil Z, et al
     Detection and investigation of invasive mould disease.
     J Antimicrob Chemother. 2011;66 Suppl 1:i15-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
135. DU XD , Liu HB, Wu CM, Li XS, et al
     The genetic environment of armA on pHNE, an IncN plasmid, in one Escherichia coli isolate from a chicken.
     J Antimicrob Chemother. 2010;65:2694-5.
     PubMed     Text format     Related articles   
     
     
     
     
136. WHILEY DM , Jacobsson S, Tapsall JW, Nissen MD, et al
     Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.
     J Antimicrob Chemother. 2010;65:2543-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. HOPE R , Mushtaq S, James D, Pllana T, et al
     Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK.
     J Antimicrob Chemother. 2010;65:2602-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
138. MORAN E , Byren I, Atkins BL
     The diagnosis and management of prosthetic joint infections.
     J Antimicrob Chemother. 2010;65 Suppl 3:iii45-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. DRYDEN MS
     Complicated skin and soft tissue infection.
     J Antimicrob Chemother. 2010;65 Suppl 3:iii35-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. POWLSON AS , Coll AP
     The treatment of diabetic foot infections.
     J Antimicrob Chemother. 2010;65 Suppl 3:iii3-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. PALLETT A , Hand K
     Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.
     J Antimicrob Chemother. 2010;65 Suppl 3:iii25-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. GOULIOURIS T , Aliyu SH, Brown NM
     Spondylodiscitis: update on diagnosis and management.
     J Antimicrob Chemother. 2010;65 Suppl 3:iii11-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. BIEK D , Critchley IA, Riccobene TA, Thye DA, et al
     Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
     J Antimicrob Chemother. 2010;65 Suppl 4:iv9-16.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. CORRADO ML
     Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
     J Antimicrob Chemother. 2010;65 Suppl 4:iv67-iv71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. WILCOX MH , Corey GR, Talbot GH, Thye D, et al
     CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
     J Antimicrob Chemother. 2010;65 Suppl 4:iv53-iv65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. COREY GR , Wilcox MH, Talbot GH, Thye D, et al
     CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
     J Antimicrob Chemother. 2010;65 Suppl 4:iv41-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. MOELLERING RC JR
     The problem of complicated skin and skin structure infections: the need for new agents.
     J Antimicrob Chemother. 2010;65 Suppl 4:iv3-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. JONES RN , Mendes RE, Sader HS
     Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
     J Antimicrob Chemother. 2010;65 Suppl 4:iv17-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
149. CATTOIR V , Varca A, Greub G, Prod'hom G, et al
     In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance.
     J Antimicrob Chemother. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: